13F Holdings
中文EN

ACAT NP Life Sciences Health Industry Group Inc.

Services-Educational Services · OTC · SEC CIK 1781726 · Fiscal year ends 12/31

Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY202.8%
TTM EPS YoY—
Revenue 3-yr CAGR112.8%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-0.5%
Net margin13.4%
FCF margin—
EBITDA margin—

Returns

ROE108.6%
ROA19.0%
ROIC (approx.)—
Asset turnover1.41x

Leverage & solvency

Liabilities / assets78.7%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income-3.80x
Accruals ratio90.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2023Q4*2023-12-312023Q32023-09-302023Q22023-06-302023Q12023-03-312022Q4*2022-12-312022Q32022-09-302022Q22022-06-302022Q12022-03-31
Income statement
Revenue-$10,015$17,515$107,099$30,000$46,020$41,000$14,982—
SG&A expense$45,869$54,960$35,707$28,775$29,420$46,440$13,905$31,092
Operating income-$35,862-$37,445$71,392$1,225$16,600-$5,440$1,077-$31,092
Pretax income-$36,507-$37,445—$1,222$16,599-$5,440$1,077-$31,092
Income tax-$20,733-$2,295——————
Net income-$15,355-$37,670$71,195$1,222$16,598-$5,440$1,078-$31,092
EPS (basic)———0.00———0.00
EPS (diluted)————————
Weighted avg. shares (diluted)—42.96M42.96M——42.96M42.96M—
Banking
Net interest income———-$3————
Balance sheet
Cash & equivalents$70,614$84,551$125,111$140,078$121,859$6,951$575$23,122
Total assets$76,864$95,321$144,106$142,448$127,784$16,944$17,035$24,801
Current liabilities$38,121———$108,468———
Total liabilities$60,483$63,585$76,995$121,910$108,468$14,226$8,877$17,721
Shareholders' equity$16,381$31,736$67,111$20,538$19,316$2,718$8,158$7,080
Shares outstanding42.96M42.96M42.96M42.96M42.96M42.96M42.96M42.96M
Cash flow statement
Operating cash flow-$13,937-$40,560-$37,329$18,219$114,908$6,376-$22,547-$4,864
Financing cash flow$0$0——————

Free plan shows the latest 8 periods; Pro shows all 20 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.